Oligodendrogliomas Terminated Phase 3 Trials for Temozolomide (DB00853)

Also known as: Oligodendroglioma / [M]Oligodendroglioma NOS / Oligodendroglioma, Well-Differentiated

IndicationStatusPhase
DBCOND0032978 (Oligodendrogliomas)Terminated3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00897377Treatment Strategy for Low-grade GliomasTreatment